10 results
DEFA14A
CNTA
Centessa Pharmaceuticals plc
20 May 24
Additional proxy soliciting materials
8:48pm
decisions in the long term
See Part I, Item 1: Business; Overview section of 10-K – p.5
the interest of the company’s employees
Diversity and inclusion … on merit according to a balance of skills and experience. Whilst acknowledging the benefits of diversity, individual appointments are made irrespective
PRE 14A
CNTA
Centessa Pharmaceuticals plc
26 Apr 24
Preliminary proxy
4:36pm
may therefore consider a broad range of factors relating to the qualifications and background of nominees, which may include diversity … and is not limited to race, gender or national origin. Whilst we take diversity very seriously, currently we have no formal policy regarding board diversity. Our
DEFA14A
CNTA
Centessa Pharmaceuticals plc
23 May 23
Additional proxy soliciting materials
4:08pm
of the company’s employees
Diversity and inclusion are important to the Group’s growth strategy and align with the Group’s values of integrity … and equality. Appointments within the Group are made on merit according to a balance of skills and experience. Whilst acknowledging the benefits of diversity
DEFA14A
lk7lcv 5xsb53s
9 Jun 22
Additional proxy soliciting materials
9:06am
DEF 14A
my6t2840
23 May 22
Definitive proxy
8:00am
10-K
m399xmrdb2k6hrgy1f
30 Mar 22
Annual report
12:00am
- Prev
- 1
- Next